Myosin modulators move forward with FDA approval of mavacamten.

TitleMyosin modulators move forward with FDA approval of mavacamten.
Publication TypeJournal Article
Year of Publication2022
AuthorsChin AC, Day SM
JournalNat Cardiovasc Res
Volume1
Issue7
Pagination595-596
Date Published2022 Jul
ISSN2731-0590
DOI10.1038/s44161-022-00093-x
Alternate JournalNat Cardiovasc Res
PubMed ID39196240
PubMed Central ID5834683

Person Type: